Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11945873 Antitumor antagonists

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Bo Liu0

Jackie Sheng0

Margaret Karow0

Date of Patent

April 2, 2024

0

Patent Application Number

173018690

Date Filed

April 16, 2021

0

Patent Citations

US Patent 7297334 Anti-vegf antibodies

0

US Patent 9676863 Targeted TGFβ inhibitors

0

US Patent 9764038 Enzymatic conjugation of antibodies

0

US Patent 9890204 Trivalent, bispecific antibodies

0

US Patent 9987500 Human antibodies to PD-1

0

US Patent 9994632 Humanized or affinity-matured anti Ang-2 antibody and uses thereof

0

US Patent 10112997 Tight-binding agents and uses thereof

0

US Patent 10189902 Antibodies to TIGIT

0

...

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

Patent abstract

Antitumor antagonists that bind specifically to immune checkpoint regulators, angiogenesis pathway regulators and/or TGF pathway regulators are disclosed. Also disclosed are methods for treating proliferative disorders, infections, and immunological disorders with the antitumor antagonists described herein.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11945873 Antitumor antagonists

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool